5-amino-1mq peptide research Vial 5-Amino-1MQ Research Compound | >99%

Your body uses what it needs, and much of the excess is filtered out by the kidneys and passed in urine

Subcutaneous administration in normal and metabolically dysregulated mice significantly inhibits NNMT activity in metabolically active tissues (adipose, liver, muscle), increases systemic NAD+ levels, enhances mitochondrial function, and improves energy metabolism

Long-Term Protocols: The most clinically relevant studies evaluated subcutaneous doses of 0.25 mg (250 mcg), 0.5 mg (500 mcg), and 1 mg (1,000 mcg) administered daily for 24 weeks

For children aged 114 years, the AIs increase with age from 1.5 to 3.5 g/day